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NOTES AND COMMENTS

In Vitro Kidney Preservation Techniques
S. G. Dienst, M.D.*
The advantages of adding hyperbaria, low flow perfusion, and protein colloid
to hypothermia at 0° C for kidney preservation are described. The possibilities of
longer preservation at higher temperatures are discussed.

The preferred method of handling
the donor kidney during transplantation continues to be rapid cooling by
flushing the kidney's vascular bed with
cold solutions, then holding its temperature at 0° C by surface cooling. With
certain adjuncts, this technique offers
good preservation of renal function for
eight hours. A longer period of reliable
preservation would allow for transportation and wider use of potential human
donor kidneys. Reports of successful
24-hour preservation, using continuous
plasma perfusion and oxygenation at
temperatures of 8° to 10°C,' have encouraged studies of these techniques
and various modifications of them.
Hypothermic preservation in its simplest form consist of flushing the kidney with cold isomotic electrolyte solution such as Ringer's lactate. Heparin
is added to prevent intravascular clotting. After the blood has been flushed
from the vascular bed, the kidney is
immersed in a partiaUy frozen saline
solution or "saline slush." It is stored

in this solution for periods as long as
six to eight hours until anastomosed to
the vessels of the recipient. In our experience the kidney thus handled does
not retain all of its potential function.
Certain additives and adjuncts have
improved the immediate response and
final function of the kidney.
Table I
Agents added to initial kidney flushing solution for preservation at 0 C.
ADDITIVES

RATIONALE
formal oncotic pressure

Potassium Ptiosphate
(or Chloride)

Reduce extra-intracellular
ion gradients

Magnesium

To conserve mitochondrial
ATP and DPN*

Phenoxybenzamine

Reduce arterial spasm

Glucose and Citrate

Oxidative substrates

Hydrocortisone
Cnlorpromazine
(Thorazine!

Stabilize lysozome and
cellular membranes

• Adenosine Triphosphate and Diphosphopyridine
Nucleotide

Albumin or plasma is used to maintain a normal oncotic pressure gradient
between the extra and intracellular
compartments. This minimizes cellular
swelling during hypothermia. This is
better accomplished with albumin*
* I n practice, concentrated "Albumisol" or
other human albumin is added to the intracellular electrolyte solution to give a six
gram percent protein solution.

* General Surgery Division I I
This work was sponsored in part by The
McGraw Foundation.
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than with dextran. Kidneys perfused
with albumin solution at 0° C have an
immediate uniform pink color when revascularized. On the other hand, kidneys perfused with dextran in an electrolyte solution have a persistent bluish
cast and do not warm rapidly, indicating poor perfusion. Also, angiograms
of the kidneys perfused with dextran
indicate obstruction of small arteries,
particularly in the medullary portion.^

through glycolysis. Citrate provides a
Kreb's cycle substrate.
For preservation longer than two
hours, intermittent low flow perfusion
and hyperbaria are carried out with the
simple Swenko* apparatus. Until now,
this perfusate has been a saline base
solution with only four mEq/1 of magnesium and no added potassium. A
flow of 200 milliliters per hour under
three atmospheres of oxygen delivers 8
miUiliters of dissolved oxygen. This is
more than is used by the human kidney
of average weight at 0°C to 1 °C. Aside
from increasing oxygen delivery, hyperbaria somehow extends preservation
through its pressure effect, possibly by
minimizing cellular edema. The slow
flow of perfusate also supplies constant
substrate and lowers the very high
PC02's which occur. The uniformly
better results with perfusion and hyperbaria suggest that the kidney at 0°C is
capable of respiration and sufficient
energy production to keep its molecular organization intact. Figure 1 shows
a typical response of the BUN in a patient after receiving a kidney stored
under hyperbaria.

Composition of the Perfusate
Potassium phosphate or chloride is
added to reduce the intra-extraceUular
gradient of sodium and potassium. This
is done to conserve the energy normally
expended to maintain these gradients.
Also, it has been shown that intracellular potassium is rapidly lost from cells
into cold perfusing solutions.^ Magnesiimi is added to reduce intracellular
losses, to inhibit ATPase, and to minimize the loss of ATP and DPN from
mitochondria. Free magnesium is also
necessary for the activity of many respiratory enzymes. Phenoxybenzamine
is a long acting alpha-adrenergic blocking agent used to prevent arterial spasm.
Recent proponents for the use of phenoxybenzamine now advocate giving it
systemically to a cadaver donor. The
use of phenoxybenzamine, magesium,
and potassium is taken from the
recent work of Collins, Bravo-Shugarman and Teraski.* This "intracellular" solution has been used successfully as a flushing solution but not yet
as a continuously flowing perfusate.
Hydrocortisone and chlorpromazine
are sometimes added to reduce the
breakdown of lysozome and cell membranes. Glucose is added as an anaerobic supply of DPNH (hydrogen ions)

Current Techniques
During the 20 to 40 minutes of vascular anastomosis, the kidney is gradually warming toward the temperature
in the operative field. The greatest temperature increase is evidenced in the
kidney cortex, which normally has the
highest metabolic rate. To prevent this
warming during the ischemia period, a
double wall silastic kidney cooling
jacket has been designed. This allows
for the circulation of cold solution
around the kidney during anastomosis.
* Swenko Incorporated, Minneapolis.
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vation. Figure 2 outlines a system incorporating oxygenation and dialysis of
the perfusate. In this Extracorporeal
circuit only cryoprecipitated plasma,
after the method of Belzer,^ or heavily
citrated plasma or serum wUl flow
through the kidney for 24 hours or
more. In our experience microclotting
is an important factor in the vascular
obstruction which is prone to occur.
Also, perfusion pressures over 50 to 60
millimeters of mercury are associated
with increasing edema and resistance to
flow. Generally, low pressures and low
temperatures (less than 8°C) yield the
best perfusion.
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Figure 1
Chart shows the ability to clear urea of the
donor kidney stored under hyperbaria.

Its ability to preserve function in the
transplanted kidney is being evaluated
in the laboratory. A human size cooling
jacket* has been used during transplant
of one cadaver (five hours total storage) and one living related kidney donation. Both patients had receive Mannitol. There was prompt diuresis of
over a liter during the first hour. Blood
urea nitrogen and serum creatinines
were normal within 36 hours and both
kidneys later had above normal creatinine clearances.
The use of the "intracellular" solution before storage at 0°C* for a period
of 24 hours has not been uniformly
successful in the laboratory. After autotransplantation, these canine kidneys
perfused well and produced urine immediately. However, even the best results show moderately elevated BUNs
and creatinines which began to climb
rapidly after five to seven days. The
final specimens showed diffuse parenchymal damage.
Perfusion of the kidney at higher
temperatures appears to be the method
which is now evolving for longer preser-

Effects of Temperature
Temperature seems to be the most
important variable in these experiments. With plasma perfusate, the temperature is limited to less than 14°C
because plasma alone cannot transport
the larger volumes of oxygen required
at higher temperatures. This narrow
range, 6°C to 14°C, has the disadvantage of retarding respiration and
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Figure 2
Diagrammatic presentation of the method
for perfusing kidneys at 10°C. The perfusate
is serum or more commonly cryoprecipitated
plasma which is continuously oxygenated
and dialyzed.

* Extracorporeal, New Jersey.
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phosphorylation and yet does not give
the full stabilizing effect of keeping
these systems near freezing. This compromise may prove to be the limiting
factor in the method.

- ConlrolleD level; of Melaholic Intermeiliates - Programmed lemperalure
—
Oxygen Delivery and Electrolyte

Current experiments are designed to
measure respiration by oxygen consumption while varying the temperature. The temperatures wUl be carried
to between 20 °C and 28°C by adding
red cells or free hemoglobin to the perfusate for increased oxygen transport.

KIDNEY

PRESERVATION METHODS

Figure 3
Effective preservation time which can be
achieved with different techniques. Perfusion
at physiological flow rates and moderately
reduced temperatures appears to be the most
promising method for reliable preservation
beyond 12 hours.

REFERENCES
1. Belzer, F. O., et al: Etiology of rising perfusion pressure in isolated organ perfusion. Ann
Surg 168:382-91, Sept 1968.
2. Dienst, S. G., and Krieg, M. A.: Initial studies of isolated kidney perfusion. Henry Ford
Hosp Med J 17:165-70, Fall 1969.
3. Keeler, R., et al: The problem of renal preservation. Brit J Urol 38:653-6, 1966.
4. Collins, G. M.; Bravo-Shugarman, M., and Terasaki. P. I . : Kidney preservation for transportation. Lancet 2:1219-22, Dec 1969.

152

Henry Ford Hospital
Detroit, Michigan

Non-Profit O r g .

48202

U. S. Postage
P A I D

Address Correction requestedForwarding and return postage guaranteed.

Detroit, M i c h .
Permit No. 6785

iJjo
ro

P r i n t e d in U . S . A .

Hi

mt

